BELKYRA Treatment at Nasseri Medical Centre & Medspa
Welcome to the official page of the revolutionary BELKYRA treatment at Nasseri Medical Centre & Medspa. We are proud to offer this non-surgical solution for individuals looking to address their double chin and submental fat concerns.
What is BELKYRA?
BELKYRA is an FDA-approved injectable treatment that targets and reduces submental fat, commonly known as a double chin. It is a synthetic form of deoxycholic acid, a natural substance found in our bodies. When injected into the fat beneath the chin, BELKYRA destroys fat cells, resulting in a more contoured and defined jawline.
The Benefits of BELKYRA
- Non-surgical: BELKYRA offers a non-surgical alternative to address submental fat, eliminating the need for invasive procedures.
- Customized treatment: Our experienced professionals tailor the treatment to your specific needs, ensuring optimal results.
- Improved profile: BELKYRA can significantly improve the appearance of your profile, enhancing your overall facial harmony.
- No downtime: Unlike surgical procedures, BELKYRA requires minimal downtime, allowing you to resume your regular activities shortly after the treatment.
- Long-lasting results: Once the fat cells are eliminated, they do not regenerate, providing long-lasting results for a more defined jawline.
The BELKYRA Procedure
Prior to the procedure, our highly trained providers will conduct a thorough consultation to assess your needs and determine if BELKYRA is suitable for you. If eligible, we will create a personalized treatment plan to achieve your desired results.
During the treatment, BELKYRA is injected into precise areas beneath the chin using a fine needle. The number of injections required depends on your individual goals and the amount of submental fat present. The overall procedure is well-tolerated by most patients and takes approximately 15 to 20 minutes.
Over time, the injected BELKYRA destroys fat cells, and as the body naturally eliminates them, you will notice a gradual improvement in your chin profile. Several treatment sessions may be necessary to achieve optimal results, with each session usually spaced four to six weeks apart.
Aftercare and Recovery
Following the BELKYRA treatment, it is common to experience localized swelling, bruising, or numbness in the chin area. These side effects are temporary and usually resolve within a week or two. Our providers will provide detailed aftercare instructions, including recommendations for managing any discomfort.
It's essential to follow all post-treatment instructions provided by our team to ensure a smooth recovery and optimal results. Avoid strenuous physical activities on the day of the treatment and apply ice packs to the treatment area as directed. If you experience any unusual symptoms or have concerns during your recovery, do not hesitate to reach out to our office for guidance.
Is BELKYRA Right for You?
If you are bothered by the appearance of a double chin or excess submental fat, BELKYRA may be the ideal solution for you. However, it is important to schedule a consultation with our skilled providers at Nasseri Medical Centre & Medspa to determine your candidacy. During the consultation, we will examine your chin area and discuss your goals to establish if BELKYRA is the right treatment option for you.
Our team of professionals is dedicated to your satisfaction and will ensure you are well-informed about the procedure, its benefits, and any potential risks involved. We prioritize your safety and strive to provide a comfortable and effective treatment experience.
Contact Nasseri Medical Centre & Medspa Today
Take the first step towards a defined and contoured jawline by scheduling a consultation with the experts at Nasseri Medical Centre & Medspa. Our team will evaluate your unique needs and recommend the best course of action to help you achieve your desired results.
Don't let submental fat hold you back from feeling confident in your appearance. Contact Nasseri Medical Centre & Medspa today and discover how BELKYRA can transform your profile.